UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000040579
Receipt No. R000046317
Scientific Title Effect of smoking on sympathetic nerve activity in heart failure
Date of disclosure of the study information 2020/05/29
Last modified on 2020/05/29 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effect of smoking on sympathetic nerve activity in heart failure
Acronym Smoking status in heart failure
Scientific Title Effect of smoking on sympathetic nerve activity in heart failure
Scientific Title:Acronym SMOKEHF
Region
Japan

Condition
Condition heart failure patients
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 It is well-known that smoking habit contribute to cardiovascuoler event. smoking is also reported to Increased sympathetic nerve activity. Recently electrical cigarrete is spreading, but its effect on sympathetic nerve activity is unclear
Basic objectives2 Others
Basic objectives -Others In this study, we examine the effect of electrical and nonelectrical smoking on muscle sympathetic nerve activity.
Trial characteristics_1 Exploratory
Trial characteristics_2 Explanatory
Developmental phase Phase I

Assessment
Primary outcomes decrease in MSNA
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <
Age-upper limit
85 years-old >
Gender Male and Female
Key inclusion criteria HF patients is defined as HF symptom, BNP>100pg/ml and left ventricular dysfunction before medication.

Smoking habit over 1years
Key exclusion criteria 1)diagnosis of HF within 1 month
2)Hemo-dialysis state
3)Uncontroled diabetes patients(HbA1c>8.0)
4)Severe autonomic dysfuntion
5)an inappropriate patient
Target sample size 45

Research contact person
Name of lead principal investigator
1st name Hisayoshi
Middle name
Last name Murai
Organization Katy Graduate School of Medical Sciencesnazawa University
Division name Department of Cardiovascular Medicine
Zip code 9208641
Address 13-1 Takara-machi, Kanazawa
TEL 076265200
Email sakurasoma1209@yahoo.co.jp

Public contact
Name of contact person
1st name Hisayoshi
Middle name
Last name Murai
Organization Katy Graduate School of Medical Sciencesnazawa University
Division name Department of Cardiovascular Medicine
Zip code 9208641
Address 13-1 Takara-machi, Kanazawa
TEL 076265200
Homepage URL
Email sakurasoma1209@yahoo.co.jp

Sponsor
Institute Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences
Institute
Department

Funding Source
Organization self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Institutional Review Board
Address 13-1 Takara-machi, Kanazawa
Tel 0762652110
Email rinri@adm.kanazawa-u.ac.jp

Secondary IDs
Secondary IDs YES
Study ID_1 2019-077 (3116)
Org. issuing International ID_1 2019-077 (3116)
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 05 Month 29 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2019 Year 08 Month 21 Day
Date of IRB
2021 Year 08 Month 21 Day
Anticipated trial start date
2019 Year 08 Month 21 Day
Last follow-up date
2021 Year 08 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information N/A

Management information
Registered date
2020 Year 05 Month 29 Day
Last modified on
2020 Year 05 Month 29 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046317